🔎 Trials Near Me

Akèy › Kansè ovè › Missouri › Kansas City

Etid klinik pou Kansè ovè nan Kansas City, MO

11 etid pou Kansè ovè ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • Saint Luke's Hospital of Kansas City, Kansas City
Laj 45 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06995898

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Ap rekriteFaz 3
  • HCA Midwest Kansas City, MidAmerica Division, Inc., Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213804

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Ap rekriteFaz 2
  • The University of Kansas Cancer Center, Westwood · 5 mi lwen
Laj 18 ak plis · Fanm · Mizajou Sep 14, 2026 · NCT06787612

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ap rekrite
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi lwen
Laj 35 a 50 · Fanm · Mizajou Aug 7, 2026 · NCT04251052

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Ap rekriteFaz 1/2
  • University of Kansas Medical Center (KUMC), Westwood · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Ap rekriteFaz 2
  • 334, Kansas City
Laj 18 ak plis · Fanm · Mizajou Jul 16, 2026 · NCT06906341

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Saint Luke's Cancer Institute, Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • The University of Kansas Cancer Center - Westwood, Westwood · 5 mi lwen
  • University of Kansas Cancer Center, Westwood · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

Integrated Cancer Repository for Cancer Research

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • ak 1 plis
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Ap rekriteFaz 3
  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Cancer Center North, Kansas City
  • University of Kansas Cancer Center Westwood, Westwood · 5 mi lwen
  • ak 1 plis
Laj 18 ak plis · Fanm · Mizajou Apr 16, 2026 · NCT05659381

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Kansas City
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè ovè nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.